Kandasamy, G.; Arumugam, V.; Orayj, K.; Alshahrani, A.M.; Alanazi, T.S.; Hmlan, A.; Venugopal, J.P.
Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study. Medicina 2025, 61, 1531.
https://doi.org/10.3390/medicina61091531
AMA Style
Kandasamy G, Arumugam V, Orayj K, Alshahrani AM, Alanazi TS, Hmlan A, Venugopal JP.
Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study. Medicina. 2025; 61(9):1531.
https://doi.org/10.3390/medicina61091531
Chicago/Turabian Style
Kandasamy, Geetha, Vijayakumar Arumugam, Khalid Orayj, Asma M. Alshahrani, Tahani S. Alanazi, Amjad Hmlan, and Jithin P. Venugopal.
2025. "Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study" Medicina 61, no. 9: 1531.
https://doi.org/10.3390/medicina61091531
APA Style
Kandasamy, G., Arumugam, V., Orayj, K., Alshahrani, A. M., Alanazi, T. S., Hmlan, A., & Venugopal, J. P.
(2025). Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study. Medicina, 61(9), 1531.
https://doi.org/10.3390/medicina61091531
